Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective multicenter real-world study of minoxidil lotion for androgenetic alopecia
ChiCTR2400090249Phase 4Recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of minoxidil in androgenetic alopecia (AGA) (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Terminal hair density in frontal and vertex target areas. Started Sep 2024; status: recruiting.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on ChiCTR2400090249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090249.